Spinverse has recently opened a new office in Berlin, in the renowned Factory Berlin HQ - first and largest startup campus in Germany, located at Rheinsberger Str. 76/77. This new presence offers excellent connections within the network of innovators consisting of freelancers, startups from all possible stages and verticals, established corporations as well as investors and leading influencers from politics, science and society. Members of the community include SoundCloud, Uber and Twitter among others.
disruptive innovation (2)
Former Intel Labs CTO Martin Curley on Open Innovation 2.0: we need to enter an era of mass collaboration
Former Vice President of Intel Labs Europe and co-founder of the Innovation Value Institute, Martin Curley, who was speaking at the CTO Forum Finland in Helsinki on October the 13th, 2016, started off his address to the Finnish CTOs by saying that we live in a new era where the pace of innovation is a matter of survival.
Spinverse is delighted to make known yet another customer success story: Finnish company IndoorAtlas secured Horizon2020 SME Instrument financing to scale-up and expand the disruptive geomagnetic indoor positioning technology delivered as a scalable cloud platform.
The European innovation and business environment is facing severe structural changes, requiring key players to continuously update strategies to maintain and foster competitiveness. Hence, a new breed of innovation is emerging. It exploits disruptive technologies to solve societal challenges sustainably and profitably by blurring the borders between research, industry and governments. It is called Open Innovation 2.0.
The latest success story: Using wind to save fuel in the global maritime industry. Finnish SME secures European funding
Shipping companies are actively looking for solutions to reduce fuel consumption and environmental emissions of vessels, particularly due to the recent fuel price instability as well as the forthcoming environmental regulations. Spinverse customer Norsepower is ready to address this challenge utilising new technology, advanced materials and leading-edge control system.
Starting in October 2016, Small and medium-sized enterprises in Finland will be able to benefit from the Innovation Voucher scheme. Introduced as a pilot venture by Tekes financial services, the Innovation Voucher is worth 5 000 € and is meant for micro-enterprises and SME’s. A company that receives the voucher can purchase professional innovation services from a service provider, that has a special know-how or expertise that the voucher recipient does not have. The Innovation Voucher is a part of the Enterprise Package that the Finnish government announced in April 2016. The package aims to promote entrepreneurship by providing SMEs with access to tools they may require to realise their innovation potential.
5 small and medium-sized companies (SMEs) from Finland have been selected in the latest round of Horizon2020 SME Instrument Phase 2. Each project receives up to € 2.5 million to finance innovation activities. Three out of five Finland’s winning cases in this cut-off secured funding with the help of Spinverse.
Disrupt or Be Disrupted: do you know what will reshape your industry?
Spinverse has joined eight other European companies, research institutes and universities in the smart-MEMPHIS project. The objective of the project is to develop new, autonomous modules for energy harvesting. Energy harvesting systems that are developed within the smart-MEMPHIS project will have many applications ranging from implantable pacemakers to aircrafts. In cardiac pacemakers, the energy generated by heart beats will be used to power the implanted devices, thus bringing significant benefits to patients and healthcare professionals alike.
Bridging the gap for production of nanopharmaceuticals - towards commercialisation of experimental HIV-vaccine
Nine European companies and research institutes combine forces in the NanoPilot-project to create a pilot plant aimed at accelerating the development of nanomedicine by facilitating the production of small clinical batches under Good Manufacturing Practice (GMP). One of the first three nanopharmaceuticals chosen for production in the pilot plant is a promising intranasal HIV vaccine.